Related Experiment Videos
Leukocytes in neuronal ceroid-lipofuscinoses: function and apoptosis
B C Kieseier1, K E Wisniewski, E Park
1Department of Pathological Neurobiology, New York State Institute for Basic Research in Developmental Disabilities, Staten Island 10314, USA.
Brain & Development
|July 1, 1997
Summary
Neuronal ceroid-lipofuscinoses (NCL) involve lysosomal storage. This study found no functional impairment in NCL patients' immune cells, but increased apoptosis suggests programmed cell death plays a key role in NCL pathogenesis.
Area of Science:
- Neuroscience
- Genetics
- Immunology
Background:
- Neuronal ceroid-lipofuscinoses (NCL) are fatal, inherited neurodegenerative diseases characterized by lysosomal accumulation of storage material.
- The underlying pathophysiological mechanisms of NCL remain largely unknown.
- Abnormal lipopigment accumulation occurs in neural and extraneural cells, including peripheral blood leukocytes.
Purpose of the Study:
- To investigate the functional capacity of immunocompetent cells in NCL patients.
- To determine if intracytoplasmic storage material impacts cellular function in NCL.
- To explore the role of cellular turnover and apoptosis in NCL pathogenesis.
Main Methods:
- Studied peripheral venous blood immunocompetent cells from ten NCL patients.
- Compared cell function in NCL patients with age- and sex-matched controls.
- Assessed cellular turnover and apoptosis rates.
Main Results:
- No significant functional impairment was observed in immunocompetent cells from NCL patients.
- A higher cellular turnover rate was suggested in NCL patients.
- Increased apoptosis was detected, indicating a potential role for programmed cell death.
Conclusions:
- Intracytoplasmic storage material in NCL does not appear to cause direct functional impairment of immunocompetent cells.
- Abnormally controlled programmed cell death (apoptosis) may be a significant factor in the pathogenesis of NCL.
- Further research into apoptosis regulation is warranted for understanding and potentially treating NCL.